TITLE

Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination

AUTHOR(S)
Gonçalves, Guilherme; Santos, Maria Augusta; Frade, João Graça; Cunha, José Saraiva
PUB. DATE
January 2007
SOURCE
BMC Public Health;2007, Vol. 7 Issue 1, p109
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The need for tetanus toxoid decennial booster doses has been questioned by some experts. Several counter arguments have been presented, supporting the maintenance of decennial adult booster doses with tetanus and diphtheria toxoids (adult formulation of the vaccine: Td). This study aimed to evaluate the use of Td in Portuguese adult women under routine conditions. For that purpose we selected a group of women 30+ years of age to which vaccination was recommended. We intended to know if pre-vaccination antibody concentrations were associated with factors as age at first and last vaccination, number of doses and time since last revaccination. We also intended to assess the serological efficacy of Td booster. Methods: Following the Portuguese guidelines 100 women were vaccinated with Td. Antitetanus toxin IgG (ATT IgG) and antidiphtheria toxin IgG (ADT IgG) levels were measured (mIU/ml) in 100 prevaccination and 91 post-vaccination sera. Detailed vaccination records were available from 88 participants. Results: Twenty-two women (Group A) began vaccination with DPT/DT in their early childhood and their pre-vaccination ATT IgG levels increased with the number of doses received (p = 0.022) and decreased with time since last vaccination (p = 0.016). Among the 66 women who began vaccination in adolescence and adulthood (Group B), with monovalent TT, ATT IgG levels decreased with age at first dose (p < 0.001) and with time since last vaccination (p = 0.041). In Group A, antidiphtheria toxin IgG kinetics was very similar to that observed for ATT IgG. Among women not vaccinated with diphtheria toxoid, ADT IgG levels decreased with age. Serological response to both components of Td was good but more pronounced for ATT IgG. Conclusion: Our study suggests that, to protect against tetanus, there is no need to administer decennial boosters to the Portuguese adults who have complied with the childhood/adolescent schedule (6 doses of tetanus toxoid). The adult booster intervals could be wider, probably of 20 years. This also seems to apply to protection against diphtheria, but issues on the herd immunity and on the circulation of toxigenic strains need to be better understood.
ACCESSION #
29361995

 

Related Articles

  • Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C. G�mez, Carmen Elena; Perdiguero, Beatriz; Jim�nez, Victoria; Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Quakkerlaar, Esther D.; Delaloye, Julie; Harari, Alexandre; Roger, Thierry; Dunhen, Thomas; S�kaly, Rafick P.; Melief, Cornelis J. M.; Calandra, Thierry; Sallusto, Federica; Lanzavecchia, Antonio; Wagner, Ralf; Pantaleo, Giuseppe; Esteban, Mariano // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and...

  • The 50-year war.  // Nature Immunology;May2005, Vol. 6 Issue 5, p421 

    The article sheds light on the 50 restless years since the advent of the Salk vaccine. The Salk vaccine (IPV) is prepared from inactivated polioviruses of the three known serotypes (types 1, 2 and 3) and is administered by subcutaneous injection. It induces circulating neutralizing antibodies...

  • Rho(D) IMMUNE GLOBULIN.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1031 

    The article presents information on Rho(D) Immune Globulin, a type of vaccine or immunizing agent. Rho(D) Immune Globulin prevents the production of anti-Rh0(D) antibodies in Rh0(D)-negative patients who were exposed to Rh0(D)-positive blood. It increases the platelet counts of patients with...

  • Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis. Setty Anand; Munirathinam Gnanasekar; Mani Thangadurai; Prince Prabhu; Perumal Kaliraj; Kalyanasundaram Ramaswamy // Parasitology Research;Sep2007, Vol. 101 Issue 4, p981 

    Abstract  A homologue of Brugia malayi venom allergen (BmVAH) was cloned from the infective stages (L3) of Wuchereria bancrofti. Sequence analysis showed 90% sequence identity between WbVAH and BmVAH. Recombinant WbVAH was then expressed and purified. VAH from other nematode...

  • Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C. Gómez, Carmen Elena; Perdiguero, Beatriz; Jiménez, Victoria; Filali-Mouhim, Abdelali; Ghneim, Khader; Haddad, Elias K.; Quakkerlaar, Esther D.; Delaloye, Julie; Harari, Alexandre; Roger, Thierry; Dunhen, Thomas; Sékaly, Rafick P.; Melief, Cornelis J. M.; Calandra, Thierry; Sallusto, Federica; Lanzavecchia, Antonio; Wagner, Ralf; Pantaleo, Giuseppe; Esteban, Mariano // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and...

  • Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT Study. Thuan Le; Cherry, James D.; Swei-Ju Chang; Knoll, Maria Deloria; Lee, Martin L.; barenkamp, Steve; Bernstein, David; Edelman, Robert; Edwards, Kathyrn M.; Greenberg, David; Keitel, Wendy; Treanor, John; Ward, Joel I. // Journal of Infectious Diseases;8/1/2004, Vol. 190 Issue 3, p535 

    As part of a prospective acellular pertussis (ACP) vaccine efficacy trial, 5 serum samples were obtained, over an 18-month period, from 101 ACP-vaccine recipients and 99 control subjects, to assess ACP antibody response and decay. Immunoglobulin (Ig) G and IgA antibodies to pertussis toxin (PT),...

  • An update on childhood immunisation. Robinson, Gina // Independent Nurse;10/20/2008, p35 

    The article presents information related to childhood vaccination or immunisation. It is stated that immunity may be active or passive. Passive immunity takes place where antibodies are transferred while active immunity is one which is produced as a consequence of vaccination or by contact with...

  • Acellular Pertussis Vaccine Boosters Combined With Diphtheria and Tetanus Toxoid Boosters for Adolescents: Safety and Immunogenicity Assessment When Preceded by Different 5-Dose DTaP/DTwP Schedules. Pichichero, Michael F.; Casey, Janet R.; Francis, Anne B.; Marsocci, Steven M.; Murphy, Marie; Hoeger, William; Cleary, Carnlyn // Clinical Pediatrics;Sep2006, Vol. 45 Issue 7, p613 

    A sixth dose of tetanus, diphtheria, acellular pertussis (Tdap) vaccine in adolescents might produce a differing reactogenicity and/or immunogenicity response depending on the composition of the 5 prior doses of DTaP or DT-whole cell pertussis (DTwP) vaccine. Reactions and immune responses...

  • The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule. Chatterjee, Sukanta; Rego, Sylvan J.; D'Souza, Fulton; Bhatia, B. D.; Collard, Alix; Datta, Sanjoy K.; Jacquet, Jeanne-Marie // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p298 

    Background: Combination vaccines improve coverage, compliance and effectively introduce new antigens to mass vaccination programmes. This was a phase III, observer-blind, randomized study of GSK Biologicals diphtheriatetanus- whole cell pertussis vaccine combined with hepatitis B and Haemophilus...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics